Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 9, 2007, Pages 1139-1147

  Masson, Patrick ^a   Froment, Marie Thérèse ^a   Gillon, Emilie ^a   Nachon, Florian ^a   Darvesh, Sultan ^b   Schopfer, Lawrence M ^c  

^a CENTRE DE RECHERCHES   (France)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Acetanilide; Active site; Aryl acylamidase; Burst; Butyrylcholinesterase; Hysteretic behavior

Indexed keywords

2 NITROACETANILIDE; 2 NITROPHENYLTRIFLUOROACETAMIDE; 3 ACETAMIDO N,N,N TRIMETHYLANILINIUM; 3 NITROACETANILADE; ACETANILIDE DERIVATIVE; AMIDE; ARYL ACYLAMIDASE; CHOLINESTERASE; ECOTHIOPATE; ESTER; ESTERASE; MUTANT PROTEIN; ORGANOPHOSPHATE; SERINE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; HYDROLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN VARIANT; STEADY STATE; STEREOCHEMISTRY; WILD TYPE;

ACETANILIDES; AMIDOHYDROLASES; AMINO ACID SUBSTITUTION; BINDING SITES; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; ECHOTHIOPHATE IODIDE; HUMANS; HYDROLYSIS; KINETICS; PROTEIN STRUCTURE, QUATERNARY; STEREOISOMERISM;

EID: 34548283950     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.06.004     Document Type: Article

References (68)

1. Massoulié J., Pezzementi L., Bon S., Krejci E., and Vallete F.M. Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41 (1993) 31-91
2. Cousin X., Strähle U., and Chatonnet A. Are there non-catalytic functions of acetylcholinesterases? Lessons from mutant animal models. BioEssays 27 (2005) 189-200
3. Darvesh S., Hopkins D.A., and Geula C. Neurobiology of butyrylcholinesterase. Nat. Neurosci. 4 (2003) 131-138
4. Duysen E.G., Li B., Darvesh S., and Lockridge O. Sensitivity of butyrylcholinesterase knockout mice to (-)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Toxicology 233 (2007) 60-69
5. Li B., Sedlacek M., Manoharam I., Boopathy R., Duysen E.G., Masson P., and Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 70 (2005) 1673-1684
6. Satoh T., and Hosokawa M. Structure, function and regulation of carboxylesterases. Chem.-Biol. Interact. 162 (2006) 195-211
7. Gardiner S.J., and Berg E.J. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol. Rev. 58 (2006) 521-590
8. Doctor B.P., and Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem.-Biol. Interact. 157-158C (2005) 167-171
9. Moore D.E., and Hess G.P. Acetylcholinesterase-catalyzed hydrolysis of an amide. Biochemistry 14 (1975) 2386-2389
10. Fujimoto D. Serotonin-sensitive aryl acylamidase activity of acetylcholinesterase. FEBS Lett. 71 (1976) 121-123
11. Hsu L.L., Halaris A.E., and Freedman D.X. Rat brain arylacylamidase: further characterization of multiple forms. Int. J. Biochem. 14 (1982) 581-584
12. George S.T., and Balasubramanian A.S. The aryl acylamidases and their relationship to cholinesterases in human serum, erythrocyte and liver. Eur. J. Biochem. 121 (1981) 177-186
13. Naush I., and Heyman E. Substance P in human plasma is degraded by dipepdidyl peptidase IV, not by cholinesterase. J. Neurochem. 44 (1986) 1354-1357
14. Checler F., Grassi J., Masson P., and Vincent J. Monoclonal antibodies allow precipitation of esteratic but not peptidasic activities associated with butyrylcholinesterase. J. Neurochem. 55 (1990) 750-755
15. Carroll R.T., and Emmerling M.R. Identification of the trypsin-like activity in commercial preparations of eel acetylcholinesterase. Biochem. Biophys. Res. Commun. 181 (1991) 537-541
16. Araki W., Nakamura S., Tanaka S., Kimura J., and Ueda K. Separation of protease activity from acetylcholinesterase of the electric eel. Neurochem. Int. 19 (1991) 537-541
17. Checler F., Grassi J., and Vincent J.-P. Cholinesterases display genuine arylacylamidase activity but are totally devoid of intrinsic peptidase activities. J. Neurochem. 62 (1994) 756-763
18. Rao R.V., Gnanamuthu C., and Balasubramanian A.S. Human cerebrospinal fluid acetylcholinesterase and butyrylcholinesterase. Evidence for identity between the serum and cerebrospinal fluid butyrylcholinesterase. Clin. Chim. Acta 183 (1989) 135-146
19. Majundar R., and Balasubramanian A.S. The solubilization of platelet membrane-bound acetylcholinesterase and aryl acylamidase by exogenous or endogenous phosphatidylinositol specific phospholipase C. Biochem. Pharmacol. 34 (1985) 4109-4115
20. Engelhardt G., Wallnofer P.R., and Plapp R. Purification and properties of an aryl acylamidase of Bacillus sphaericus, catalyzing the hydrolysis of various phenylamide herbicides and fungicides. Appl. Microbiol. 26 (1973) 709-718
21. Shimizu S., Ogawa J., Chung M.C.-M., and Yamada H. Purification and characterization of a novel enzyme, arylalkyl acylamidase, from Pseudomonas putida Sc2. Eur. J. Biochem. 209 (1992) 375-382
22. Cassida J., and Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Toxicol. 17 (2004) 983-998
23. Probst M.R., Jeno P., and Meyer U.A. Purification and characterization of a human liver arylacetamide deacylase. Biochem. Biophys. Res. Commun. 177 (1991) 453-459
24. Junge W., and Krisch K. The carboxylesterases/amidases of mammalian liver and their possible significance. CRC Crit. Rev. Food Sci. Nutr. 3 (1975) 371-434
25. Satoh T. Role of carboxylesterases in xenobiotic metabolism. Rev. Biochem. Toxicol. 8 (1987) 155-181
26. Redinbo M.R., and Potter P.M. Mammalian carboxylesterases. Drug Discov. Today 10 (2005) 313-325
27. Hsu L.L. Brain aryl acylamidase. Int. J. Biochem. 14 (1982) 1037-1042
28. George S.T., and Balasubramanian A.S. The identity of the serotonine-sensitive aryl acylamidase with acetylcholinesterase from human erythrocytes, sheep basal ganglia and electric eel. Eur. J. Biochem. 111 (1980) 511-524
29. Hsu L.L., Halaris A.E., and Freedman D.X. Rat brain aryl acylamidase: further characterization of multiple forms. Int. J. Biochem. 14 (1982) 581-584
30. Majumdar R., George S.T., and Balasubramanian A.S. Serotonin-sensitive aryl acylamidase activity of platelet acetylcholinesterase. Biochem. Pharmacol. 31 (1982) 2319-2325
31. Cahill G.M., and Besharse J.C. Retinal melatonin is metabolized within the eye of Xenopus laevis. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 1098-1102
32. Balasubramanian A.S., and Banumathy C.D. Noncholinergic functions of cholinesterases. FASEB J. 7 (1993) 1354-1358
33. Boopathy R., and Layer P.G. Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development. Prot. J. 23 (2004) 325-333
34. Guillozet A.L., Smiley J.F., Mash D.C., and Mesulam M.M. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 42 (1997) 909-918
35. Nicolet Y., Lockridge O., Masson P., Fontecilla-Camps J.C., and Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J. Biol. Chem. 278 (2003) 41141-41147
36. Zhan C.-G., and Gao D. Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine. Biophys. J. 89 (2005) 3863-3872
37. Quinn D. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem. Rev. 87 (1987) 955-979
38. Johnson J.L., Cusack B., Davies M.P., Fauq A., and Rosenberry T.L. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate. Biochemistry 42 (2003) 5438-5452
39. Darvesh S., McDonald R.S., Darvesh K.V., Mataija D., Mothana S., Cook H., Carneiro K.M., Richard N., Walsh R., and Martin E. On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases. Bioorg. Med. Chem. 14 (2006) 4586-4599
40. Majundar R., and Balasubramanian A.S. Chemical modification of acetylcholinesterase from eel and basal ganglia: effect on the acetylcholinesterase and aryl acylamidase activities. Biochemistry 23 (1984) 4088-4093
41. Boopathy R., and Balasubramanian A.S. Chemical modification of the bifunctional pseudocholinesterase. Effect on the pseudocholinesterase and aryl acylamidase activities. Eur. J. Biochem. 151 (1985) 351-360
42. Costagli C., and Galli A. Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease. Biochem. Pharmacol. 55 (1998) 1733-1737
43. Stein R.L. Enzymatic hydrolysis of p-nitroacetanilide: mechanistic studies of the aryl acylamidase from Pseudomonas fluorescens. Biochemistry 41 (2002) 991-1000
44. Masson P., Schopfer L.M., Froment M.-T., Debouzy J.-C., Nachon F., Gillon E., Lockridge O., Hrabovska A., and Goldstein B.N. Hysteresis of butyrylcholinesterase in the approach to steady-state. Chem.-Biol. Interact. 157-158 (2005) 143-152
45. Lockridge O., Schopfer L.M., Winger G., and Woods J.H. Large-scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys: a potential new therapeutic for protection against cocaine and nerve agent toxicity. J. Med. Chem. Biol. Radiolog, Def. 3 (2005) (online publication)
46. Ceppa F., Kenane N., Chellak S., Bigaillon C., and Burnat P. Prolonged succinylcholine-induced apnoea associated with cholinesterase silent plasma variant. Ann. Fr. Anesth. Reanim. 24 (2005) 425-427
47. Hoagland R.E., and Graf G. Nitroacetanilides as chromogenic substrate for assaying de-acetylating activity: the isolation and partial purification of aryl acylamidases from erepsin and tulip. Enzymologia 41 (1971) 313-319
48. Ellman G.L., Courtney K.D., Andres V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
49. Masson P., Legrand P., Bartels C.F., Froment M.-T., Schopfer L.M., and Lockridge O. Role of aspartate 70 and tryptophan 82 in binding of succinyldithiocholine to human butyrylcholinesterase. Biochemistry 36 (1997) 2266-2277
50. Amitai G., Moorad D., Adani R., and Doctor B.P. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon. Biochem. Pharmacol. 56 (1998) 293-299
51. Kitz R., and Wilson I.B. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterases. J. Biol. Chem. 237 (1962) 3245-3249
52. Rajesh R.V., Biju T., Indumathi M., and Boopathy R. Does aryl acylamidase of butyrylcholinesterase have any physiological function?. Proc. IXth International Meeting on Cholinesterases, Suzhou, China, May 6-10 (2007) 32
53. Manoharam I., and Boopathy R. Diisopropylfluorophosphate-sensitive aryl acylamidase activity of fatty acid free human serum albumin. Arch. Biochem. Biohys. 452 (2006) 186-188
54. P. Masson, M.-T. Froment, S. Darvesh, L.M. Schopfer, O. Lockridge, Aryl acylamidase activity of human serum albumin with o-nitrotrifluoroacetanilide as the substrate, J. Enz. Inhib. Med. Chem. (in press), doi:10.1080/14756360701383932.
55. Masson P., Froment M.-T., Fortier P.-L., Visicchio J.-E., Bartels C.B., and Lockridge O. Butyrylcholinesterase-catalyzed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters. Biochim. Biophys. Acta 1387 (1998) 41-52
56. Masson P., Froment M.-T., Fort S., Ribes F., Bec N., Balny C., and Schopfer L.M. Butyrylcholinesterase-catalyzed hydrolysis of N-methylindoxyl acetate: analysis of volume changes upon reaction and hysteretic behavior. Biochim. Biophys. Acta 1597 (2002) 229-243
57. Masson P., Goldstein B.N., Debouzy J.-C., Froment M.-T., Lockridge O., and Schopfer L.M. Damped oscillatory hysteretic behaviour of butyrylcholinesterase with benzoylcholine as substrate. Eur. J. Biochem. 271 (2004) 220-234
58. Frieden C. Slow transitions and hysteretic behavior in enzymes. Annu. Rev. Biochem. 48 (1979) 241-471
59. Loudon G.M., and Koshland D.E. Diagnostic relationships in the relaxation spectrometry of allosteric enzymes. Biochemistry 11 (1971) 237-258
60. Darvesh S., Walsh R., Kumar R., Caines A., Roberts S., Magee D., Rockwood K., and Martin E. Inhibition of human cholinesterases by drugs used to treat Alzheimer disease. Alzheimer Dis. Assoc. Disord. 17 (2003) 117-126
61. Masson P., Xie W., Froment M.-T., Levitsky V., Fortier P.-L., Albaret C., and Lockridge O. Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates. Biochim. Biophys. Acta 1433 (1999) 281-293
62. Masson P., Froment M.-T., Gillon E., Nachon F., Lockridge O., and Schopfer L.M. Hydrolysis of oxo- and thio-esters by human butyrylcholinesterase. Biochim. Biophys. Acta 1774 (2007) 16-34
63. Masson P., Adkins S., Gouet P., and Lockridge O. Recombinant human butyrylcholinesterase G390V, the fluoride-2 variant, expressed in Chinese hamster ovary cells, is a low affinity variant. J. Biol. Chem. 268 (1993) 14329-14341
64. Boopathy R., Rajesh R.V., Darvesh S., and Layer P.G. Human serum cholinesterase from liver pathological samples exhibit highly elevated aryl acylamidase activity. Clin. Chim. Acta 380 (2007) 151-156
65. Montenegro M.F., Moral-Naranjo M.T., Paez de la Cadena M., Campoy F.J., Munoz-Delgado E., and Vidal C.J. The level of aryl acylamidase activity displayed by human butyrylcholinesterase depends on its molecular distribution. Proc. IXth International Meeting on Cholinesterases, Suzhou, China, May 6-10 (2007) 129
66. Lockridge O. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol. Ther. 47 (1990) 35-60
67. Matzke S.M., Oubre J.L., Caranto G.R., Gentry M.K., and Galbicka G. Behavioral and immunological effects of exogenous butyrylcholinesterase in rhesus monkeys. Pharmacol. Biochem. Behav. 62 (1999) 523-530
68. Saxena A., Sun W., Luo C., Myers T.M., Koplovitz I., Lenz D.E., and Doctor B. Bioscavenger for protection from toxicity of organophosphorus compounds. J. Mol. Neurosci. 30 (2006) 145-147